{"id":3911,"date":"2024-07-01T11:00:35","date_gmt":"2024-07-01T02:00:35","guid":{"rendered":"https:\/\/www.nano-hd.com\/en\/?page_id=7"},"modified":"2026-04-03T17:52:59","modified_gmt":"2026-04-03T08:52:59","slug":"company","status":"publish","type":"page","link":"https:\/\/www.nano-hd.com\/en\/company\/","title":{"rendered":"About Nano Holdings"},"content":{"rendered":"
\n

Nano Holdings is a Strategic Investment Holding Company
that combines equity and fund management
to create a unique business model.<\/p>\n<\/div>\n

\n
<\/div>\n

NANO BOARD MEMBER<\/h2>\n
\n

\u00a0<\/span><\/p>\n

\n \n \n \n \n <\/radialGradient>\n <\/defs>\n\n \n \n\n \n \n\n \n \n<\/svg>\n\n
\n
\n
\n

Atsushi Matsumura<\/p>\n

Chairperson of the Board<\/p>\n

Career Summary<\/div>\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Apr. 1986<\/th>\nJoined Nomura Securities, Co., Ltd<\/td>\n<\/tr>\n
Jan. 2008<\/th>\nRepresentative Director of Quiet Partners Inc.<\/td>\n<\/tr>\n
Sep. 2010<\/th>\nPresident of Whiz Partners Inc.<\/td>\n<\/tr>\n
Mar. 2012<\/th>\nDirector of the Company<\/td>\n<\/tr>\n
Mar. 2017<\/th>\nDirector of ALBERT Inc.<\/td>\n<\/tr>\n
Dec. 2019<\/th>\nChairman of the board of AXEL MARK INC.<\/td>\n<\/tr>\n
Apr. 2020<\/th>\nChairman of the board of Axcelead, Inc.<\/td>\n<\/tr>\n
May 2020<\/th>\nPresident and CEO of Whiz Partners Inc.<\/td>\n<\/tr>\n
Mar. 2021<\/th>\nDirector of AXEL MARK INC.<\/td>\n<\/tr>\n
Jun. 2021<\/th>\nDirector of the Company<\/td>\n<\/tr>\n
Jan. 2023<\/th>\nChairman and Director of the Company<\/td>\n<\/tr>\n
Jun. 2025<\/th>\nRepresentative Director, Chairperson of the Board<\/td>\n<\/tr>\n
Dec. 2025<\/th>\nRepresentative Director, Chairman, President & CEO (Current)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n

Satoru Iino<\/p>\n

Member of the Board, CIO<\/p>\n

Career Summary<\/div>\n
\n\n\n\n\n\n\n\n\n\n\n\n\n
Apr. 1989<\/th>\nJoined Hitachi, Ltd.<\/td>\n<\/tr>\n
Mar. 2000<\/th>\nJoined CSK Venture Capital Co., Ltd.<\/td>\n<\/tr>\n
Feb. 2004<\/th>\nDirector at the same company<\/td>\n<\/tr>\n
Sep. 2010<\/th>\nExecutive Officer at With Partners Co., Ltd.<\/td>\n<\/tr>\n
Mar. 2012<\/th>\nDirector at our company<\/td>\n<\/tr>\n
Mar. 2015<\/th>\nManaging Director and CIO of Fund Business at With Partners Co., Ltd.<\/td>\n<\/tr>\n
Jun. 2021<\/th>\nDirector at our company;
Director, COO and Co-CIO at With Partners Co., Ltd.<\/td>\n<\/tr>\n
Apr. 2024<\/th>\nPresident and Representative Director at With Partners Co., Ltd.<\/td>\n<\/tr>\n
Jul. 2025<\/th>\nSenior Advisor at our company<\/td>\n<\/tr>\n
Dec. 2025<\/th>\nMember of the Board, CIO (Chief Investment Officer)\u00a0 (Current)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Nobuhiro Todokoro<\/p>\n

Member of the Board, CGO<\/p>\n

Career Summary<\/div>\n
\n\n\n\n\n\n\n\n\n\n\n\n\n
Apr. 1989<\/th>\nJoined Nitto Denko Corporation<\/td>\n<\/tr>\n
Jun. 2015<\/th>\nExecutive Officer and General Manager of Information Functional Materials Division at the same company<\/td>\n<\/tr>\n
Apr. 2017<\/th>\nExecutive Officer and Head of Information Functional Materials Division at the same company<\/td>\n<\/tr>\n
Jun. 2017<\/th>\nDirector and Senior Executive Officer, Head of Information Functional Materials Division at the same company<\/td>\n<\/tr>\n
Jun. 2019<\/th>\nDirector and Managing Executive Officer at the same company<\/td>\n<\/tr>\n
Jun. 2021<\/th>\nDirector and Senior Managing Executive Officer at the same company<\/td>\n<\/tr>\n
Jun. 2022<\/th>\nRepresentative Director and Senior Managing Executive Officer at the same company<\/td>\n<\/tr>\n
Jun. 2024<\/th>\nPresident and CEO of Axcelead, Inc.<\/td>\n<\/tr>\n
Jul. 2025<\/th>\nSenior Advisor at our company<\/td>\n<\/tr>\n
Dec. 2025<\/th>\nMember of the Board, CGO (Chief Growth Officer) (Current)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Takashi Matsuo<\/p>\n

Member of the Board, CFO\/CAO\/COO<\/p>\n

Career Summary<\/div>\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Apr. 1984<\/th>\nJoined YAMAZEN CORPORATION<\/td>\n<\/tr>\n
Apr. 1998<\/th>\nGeneral Manager of Corporate Planning Department of AUTOBACS SEVEN Co., Ltd.<\/td>\n<\/tr>\n
Jun. 2002<\/th>\nDirector and Executive Officer in charge of Corporate Planning, Finance & Accounting, PR and IR and General Manager of Corporate Planning Management Office of AUTOBACS SEVEN Co., Ltd.<\/td>\n<\/tr>\n
Jun. 2004<\/th>\nDirector and Officer in charge of Corporate Strategy Promotion and General Manager of Corporate Planning Management Office of AUTOBACS SEVEN Co., Ltd.<\/td>\n<\/tr>\n
Apr. 2006<\/th>\nDirector and CSO and Head of Corporate Strategy Promotion of AUTOBACS SEVEN Co., Ltd.<\/td>\n<\/tr>\n
May 2007<\/th>\nDirector and CSO, Head of Corporate Strategy Promotion and Co-COO and Head of Overseas Business Strategy Promotion of AUTOBACS SEVEN Co., Ltd.<\/td>\n<\/tr>\n
Apr. 2010<\/th>\nRepresentative Director and President of TAIYO Co., Ltd.<\/td>\n<\/tr>\n
Apr. 2013<\/th>\nRepresentative Director and President of AUTOBACS Nankai Ltd.<\/td>\n<\/tr>\n
Apr. 2014<\/th>\nRepresentative Director and President of AUTOBACS Fukuoka Ltd.<\/td>\n<\/tr>\n
Apr. 2021<\/th>\nCouncilor of AUTOBACS Minami-Nihon Sales, Ltd.<\/td>\n<\/tr>\n
Jun. 2023<\/th>\nAudit & Supervisory Board Member of the Company<\/td>\n<\/tr>\n
Aug. 2023<\/th>\nRepresentative Director of Value Create Inc. (Current)<\/td>\n<\/tr>\n
Jun. 2025<\/th>\nDirector of the Company<\/td>\n<\/tr>\n
April. 2026<\/th>\nMember of the Board,CFO\/ CAO (Chief Administrative Officer)\/COO(Chief Compliance Officer) (Current)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

<\/p>\n

\n

 <\/p>\n

Shiro Akinaga<\/p>\n

Member of the Board, CTO<\/p>\n

Career Summary<\/div>\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Apr. 1981<\/th>\nJoined Kyowa Hakko Kogyo Co., Ltd. (currently Kyowa Kirin Co., Ltd.)<\/td>\n<\/tr>\n
Apr. 1994<\/th>\nSenior Researcher at pharmaceutical research center of Kyowa Hakko<\/td>\n<\/tr>\n
Apr. 2001<\/th>\nTherapeutic Area Manager of oncology group at Drug Discovery Research Division of Kyowa Hakko<\/td>\n<\/tr>\n
Apr. 2006<\/th>\nServed as Director of International Development Department and Director of Clinical Development I Department, R&D Division of Kyowa Hakko<\/td>\n<\/tr>\n
Oct. 2008<\/th>\nDirector, Clinical Development I Department, Development Division of Kyowa Hakko Kirin Co., Ltd. (currently Kyowa Kirin Co., Ltd.)<\/td>\n<\/tr>\n
Mar. 2011<\/th>\nExecutive Officer (International Development) of Kyowa Hakko Kirin<\/td>\n<\/tr>\n
Mar. 2013<\/th>\nFellow of Kyowa Hakko Kirin<\/td>\n<\/tr>\n
Mar. 2017<\/th>\nDirector and CSO of AccuRna, Inc.<\/td>\n<\/tr>\n
Nov. 2018<\/th>\nChairman of the board, CEO of AccuRna, Inc.<\/td>\n<\/tr>\n
Jun. 2020<\/th>\nDirector of the Company<\/td>\n<\/tr>\n
Sep. 2020<\/th>\nManaging Director of R&D Division & CSO of the Company<\/td>\n<\/tr>\n
Sep. 2022<\/th>\nRepresentative Director and President of PrimRNA, Inc.<\/td>\n<\/tr>\n
Dec. 2022<\/th>\nPresident and CEO, Managing Director of R&D Division & CSO of the Company<\/td>\n<\/tr>\n
Oct. 2023<\/th>\nPresident and CEO<\/td>\n<\/tr>\n
Dec. 2025<\/th>\nMember of the Board, CTO (Chief Technology Officer) (Current)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Ichiro Nakatomi<\/p>\n

Member of the Board, CNO<\/p>\n

Career Summary<\/div>\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Apr. 1978<\/th>\nJoined Hisamitsu Pharmaceutical Co., Inc.<\/td>\n<\/tr>\n
Jan. 1991<\/th>\nVice President of Business Development at TheraTech Inc. (USA)<\/td>\n<\/tr>\n
Oct. 1993<\/th>\nConcurrent position: President and Representative Director of Japan Ceratec Co., Ltd.<\/td>\n<\/tr>\n
Jun. 1996<\/th>\nPresident and CEO of our company<\/td>\n<\/tr>\n
Aug. 2008<\/th>\nOutside Director at iPS Academia Japan, Inc.<\/td>\n<\/tr>\n
Oct. 2013<\/th>\nOutside Director at OP NanoPharma Co., Ltd. (Taiwan) (Current)<\/td>\n<\/tr>\n
Jul. 2014<\/th>\nOutside Director at iPS Portal Co., Ltd.<\/td>\n<\/tr>\n
May 2020<\/th>\nRepresentative Director at Avida Science Co., Ltd.;
\nAdvisor at Oji Pharma Co., Ltd. (Current)<\/td>\n<\/tr>\n
Apr. 2021<\/th>\nAdvisor at Tokyo University of Science Educational Corporation (Current)<\/td>\n<\/tr>\n
May 2025<\/th>\nSpecial Advisor at our company<\/td>\n<\/tr>\n
Dec. 2025<\/th>\nMember of the Board, CNO (Chief Network Officer) (Current)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Hajime Kurozu<\/p>\n

Member of the Board<\/p>\n

Career Summary<\/div>\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Apr. 1982<\/th>\nJoined Nomura Securities, Co., Ltd.<\/td>\n<\/tr>\n
Apr. 2003<\/th>\nVarious senior positions at Nomura Securities, Co., Ltd., including General Manager of Corporate Finance Department I and General Manager of Osaka Finance Department I<\/td>\n<\/tr>\n
Oct. 2007<\/th>\nSeconded to Nomura Asset Management Co., Ltd.<\/td>\n<\/tr>\n
Dec. 2010<\/th>\nSeconded to LIC Nomura Mutual Fund Asset Management Pvt. Ltd. (India)<\/td>\n<\/tr>\n
Mar. 2016<\/th>\nVarious senior positions at Rating and Investment Information, Inc., including Managing Executive Officer and General Manager of RM Division in charge of RM Division, Market Sales Department, and Hong Kong Office; Head of Hong Kong Office; Manager in charge of Marketing Division<\/td>\n<\/tr>\n
Apr. 2017<\/th>\nManaging Executive Officer in charge of RM Division, Market Sales Department, and Hong Kong Office at Rating and Investment Information, Inc.<\/td>\n<\/tr>\n
Mar. 2019<\/th>\nSenior Managing Executive Officer responsible for Sales, and in charge of Marketing Division, and Head of Hong Kong Office at Rating and Investment Information, Inc.<\/td>\n<\/tr>\n
Mar. 2021<\/th>\nDirector and Senior Managing Executive Officer responsible for Sales, and in charge of Marketing Division, and Head of Hong Kong Office at Rating and Investment Information, Inc.<\/td>\n<\/tr>\n
Mar. 2024<\/th>\nPresident and CEO of P-ALM Capital Co., Ltd. (Current)<\/td>\n<\/tr>\n
Jun. 2024<\/th>\nAudit & Supervisory Board Member of the Company<\/td>\n<\/tr>\n
Dec. 2025<\/th>\nDirector at our company (Current)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Takashi Ejiri<\/p>\n

Member of the Board<\/p>\n

Career Summary<\/div>\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Apr. 1969<\/th>\nRegistered as Attorney<\/td>\n<\/tr>\n
Nov. 1977<\/th>\nPartner at Masuda Ejiri Law Office (now Nishimura & Asahi Law Firm)<\/td>\n<\/tr>\n
Sep. 1986<\/th>\nVice Chairman of International Exchange Committee, Japan Federation of Bar Associations<\/td>\n<\/tr>\n
Nov. 1998<\/th>\nAuditor at USEN Corporation (formerly Yusen Broadband Networks Co., Ltd.)<\/td>\n<\/tr>\n
Jun. 2003<\/th>\nAuditor at Aozora Bank, Ltd.<\/td>\n<\/tr>\n
Jun. 2004<\/th>\nAuditor at Ando Construction Co., Ltd. (now Ando Hazama Corporation)<\/td>\n<\/tr>\n
Jun. 2006<\/th>\nAuditor at Kagome Co., Ltd.<\/td>\n<\/tr>\n
May 2010<\/th>\nAuditor at Mitsubishi UFJ Securities Holdings Co., Ltd.;
\nAuditor at Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.;
\nOutside Auditor at DIP Corporation<\/td>\n<\/tr>\n
Aug. 2010<\/th>\nMember of Nishimura & Asahi Law Firm<\/td>\n<\/tr>\n
Mar. 2017<\/th>\nOutside Director at ALBERT Inc.<\/td>\n<\/tr>\n
Jun. 2017<\/th>\nOutside Director at OBIC Co., Ltd. (Current)<\/td>\n<\/tr>\n
Aug. 2017<\/th>\nSenior Partner at ITN Law Firm (formerly Natori Law Office) (Current)<\/td>\n<\/tr>\n
Dec. 2019<\/th>\nOutside Director (Audit Committee Member) at Axel Mark Inc.<\/td>\n<\/tr>\n
Dec. 2025<\/th>\nDirector at our company (Current)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

<\/p>\n<\/div>\n

\n
\n

Seiichiro Wada<\/p>\n

Audit & Supervisory Board Member<\/p>\n

Career Summary<\/div>\n
\n\n\n\n\n\n\n\n\n\n\n\n
Apr. 1986<\/th>\nJoined Nomura Securities Co., Ltd.<\/td>\n<\/tr>\n
Jul. 2008<\/th>\nHead of Real Estates Investment Business Department of Nomura Securities Co., Ltd.<\/td>\n<\/tr>\n
Apr. 2013<\/th>\nHead of Overseas Sales Department of Nomura Real Estate Asset Management Co., Ltd.<\/td>\n<\/tr>\n
Oct. 2014<\/th>\nManaging Director of Nomura Real Estate Asset Management Co., Ltd.<\/td>\n<\/tr>\n
Apr. 2015<\/th>\nExecutive Managing Director of Nomura Real Estate Asset Management Co., Ltd.<\/td>\n<\/tr>\n
Apr. 2017<\/th>\nAudit and supervisory board member of Nomura Real Estate Asset Management Co., Ltd.<\/td>\n<\/tr>\n
Jun. 2023<\/th>\nAuditors to the Company<\/td>\n<\/tr>\n
Jul. 2023<\/th>\nManaging Director, Whiz Partners Inc.<\/td>\n<\/tr>\n
Dec. 2025<\/th>\nFull-time Auditor at our company (Current)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Niro Sakamoto<\/p>\n

Audit & Supervisory Board Member<\/p>\n

Career Summary<\/div>\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Apr. 1983<\/th>\nJoined Kyowa Hakko Kogyo Co., Ltd. (currently Kyowa Kirin Co., Ltd.)<\/td>\n<\/tr>\n
Apr. 2006<\/th>\nDirector of Biochemical Planning and Management Department of Kyowa Hakko<\/td>\n<\/tr>\n
Jul. 2007<\/th>\nExecutive Officer and General Manager of Corporate Planning Department of Daiichi Fine Chemical Co., Ltd<\/td>\n<\/tr>\n
Apr. 2010<\/th>\nDirector of Accounting Department of Kyowa Hakko Kirin Co., Ltd. (currently Kyowa Kirin Co., Ltd.)<\/td>\n<\/tr>\n
Apr. 2012<\/th>\nExecutive Officer and Director of Corporate Planning Department of Kyowa Hakko Kirin<\/td>\n<\/tr>\n
Apr. 2015<\/th>\nExecutive Officer and Director of General Affairs Department of Kyowa Hakko Kirin<\/td>\n<\/tr>\n
Mar. 2021<\/th>\nOutside Company Auditor of Chiome Bioscience Inc.<\/td>\n<\/tr>\n
Nov. 2021<\/th>\nDirector of Administration Department of Kyulux, Inc. (Current)<\/td>\n<\/tr>\n
Mar. 2025<\/th>\nOutside Director (Audit and Supervisory Committee Member) of Chiome Bioscience Inc. (Current)<\/td>\n<\/tr>\n
Jun. 2025<\/th>\nAuditors to the Company (Current)<\/td>\n<\/tr>\n
<\/th>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Takuma Shimizu<\/p>\n

Audit & Supervisory Board Member<\/p>\n

Career Summary<\/div>\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Oct. 2002<\/th>\nRegistration as an Attorney at law Joined Asahi and Koma Law Office (currently Nshimura & Asahi)<\/td>\n<\/tr>\n
Apr. 2007<\/th>\nPartner of Iota law and patent offices<\/td>\n<\/tr>\n
Apr. 2012<\/th>\nPart-time Professor of Faculty of Law of Department of Law of Keio University (Current)<\/td>\n<\/tr>\n
Sep. 2012<\/th>\nAudit and supervisory board member of ABEJA, Inc. (Current)<\/td>\n<\/tr>\n
Oct. 2014<\/th>\nOutside Company Auditor of CRE, Inc.<\/td>\n<\/tr>\n
Oct. 2015<\/th>\nOutside Director, Audit and Supervisory Committee Member of CRE, Inc. (Current)<\/td>\n<\/tr>\n
Mar. 2017<\/th>\nRepresentative Partner of Iota law and patent offices (Current)<\/td>\n<\/tr>\n
Mar. 2018<\/th>\nSupervisory Officers of KAJIMA Private REIT, Inc. (Current)<\/td>\n<\/tr>\n
Mar. 2019<\/th>\nOutside Company Auditor of CBcloud Co., Ltd. (Current)<\/td>\n<\/tr>\n
Apr. 2022<\/th>\nOutside Company Auditor of DUAL Holdings Corp.<\/td>\n<\/tr>\n
Mar. 2024<\/th>\nOutside Director of DUAL Holdings Corp.<\/td>\n<\/tr>\n
Jun. 2025<\/th>\nAuditors to the Company(Current)<\/td>\n<\/tr>\n
<\/th>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

<\/p>\n<\/div>\n<\/div>\n<\/div>\n

\n
<\/div>\n

Corporate Profile<\/h2>\n
\n

\u00a0<\/span><\/p>\n

\n \n \n \n \n <\/radialGradient>\n <\/defs>\n\n \n \n\n \n \n\n \n \n<\/svg>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Corporate Name<\/th>\nNano Holdings, Inc.<\/td>\n<\/tr>\n
Location<\/th>\n\n
\n
Head office<\/h5>\n

Atago Green Hills MORI Tower 26F
2-5-1 Atago, Minato-ku, Tokyo
TEL: +81 (0)3-6432-0020
FAX: +81 (0)3-6432-4794<\/p>\n

Map<\/a><\/div>\n<\/div>\n
\n
<\/div>\n<\/div>\n<\/td>\n<\/tr>\n
<\/th>\n<\/td>\n<\/tr>\n
Establishment<\/th>\nJune 14, 1996<\/td>\n<\/tr>\n
Representative Director<\/th>\n\n

Representative Director, Chairman, President & CEO<\/span>Atsushi Matsumura<\/span><\/p>\n<\/td>\n<\/tr>\n

Scopes of Business<\/th>\nInvestment business<\/td>\n<\/tr>\n
Subsidiary Company<\/th>\nNANO MRNA Co., Ltd.<\/td>\n<\/tr>\n
Nano Holdings US, LCC<\/td>\n<\/tr>\n
Nano Bridge Investment Co., Ltd.<\/td>\n<\/tr>\n
History<\/th>\nPage More<\/a><\/td>\n<\/tr>\n
Access<\/th>\nPage More<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Nano Holdings is a Strategic Investment Holding Company that combines equity and fund management to create a u […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":10,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nano-hd.com\/en\/wp-json\/wp\/v2\/pages\/3911"}],"collection":[{"href":"https:\/\/www.nano-hd.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.nano-hd.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.nano-hd.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nano-hd.com\/en\/wp-json\/wp\/v2\/comments?post=3911"}],"version-history":[{"count":97,"href":"https:\/\/www.nano-hd.com\/en\/wp-json\/wp\/v2\/pages\/3911\/revisions"}],"predecessor-version":[{"id":4725,"href":"https:\/\/www.nano-hd.com\/en\/wp-json\/wp\/v2\/pages\/3911\/revisions\/4725"}],"wp:attachment":[{"href":"https:\/\/www.nano-hd.com\/en\/wp-json\/wp\/v2\/media?parent=3911"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}